The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
NCT: NCT05754281 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to evaluate the accuracy of the Cambridge Medical Technologies, LLC second generation (2nd Gen) LabPatch glucose sensing system compared to a laboratory glucose analyzer (YSI 2300 STAT Plus) and 2 commercial glucometers, OneTouch Verio and Freestyle Lite. The primary endpoint of this study is the mean absolute relative difference (MARD) for 2nd Gen LabPatch system compared to each of the above mentioned glucose references over a 6 hour outpatient visit.
Frequently Asked Questions
What is The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System?
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System is a clinical trial registered under NCT05754281. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05754281?
The current status of NCT05754281 (The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System) is: ACTIVE_NOT_RECRUITING.
When did The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System start?
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System started on 2023-02-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.